Literature DB >> 29630037

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats.

Shingo Hirao1, Hidetoshi Masumoto2, Tatsuya Itonaga1, Kenji Minatoya1.   

Abstract

Cardiopulmonary bypass (CPB) is indispensable in cardiovascular surgery. Despite the dramatic refinement of CPB technique and devices, multi-organ complications related to prolonged CPB still compromise the outcome of cardiovascular surgeries, and may worsen postoperative morbidity and mortality. Animal models recapitulating the clinical usage of CPB enable the clarification of the pathophysiological processes that occur during CPB, and facilitate pre-clinical studies to develop strategies protecting against these complications. Rat CPB models are advantageous because of their greater cost-effectiveness, convenient experimental processes, abundant testing methods at the genetic or protein levels, and genetic consistency. They can be used for investigating the immune system activation and synthesis of proinflammatory cytokines, compliment activation, and production of oxygen free radicals. The rat models have been refined and have gradually taken the place of large-animal models. Here, we describe a simple CPB model without transfusion and/or inotropic agents in a rat. This recovery model allows the study of the long-term multiple organ sequelae of CPB.

Entities:  

Mesh:

Year:  2018        PMID: 29630037      PMCID: PMC5933247          DOI: 10.3791/56986

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  21 in total

Review 1.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.

Authors:  D Paparella; T M Yau; E Young
Journal:  Eur J Cardiothorac Surg       Date:  2002-02       Impact factor: 4.191

2.  Doxycycline attenuates acute lung injury following cardiopulmonary bypass: involvement of matrix metalloproteinases.

Authors:  Chang-Tian Wang; Lei Zhang; Hai-Wei Wu; Lei Wei; Biao Xu; De-Min Li
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

3.  Fetal mesenchymal stem cells ameliorate acute lung injury in a rat cardiopulmonary bypass model.

Authors:  Tomofumi Taki; Hidetoshi Masumoto; Masaki Funamoto; Kenji Minakata; Kazuhiro Yamazaki; Tadashi Ikeda; Ryuzo Sakata
Journal:  J Thorac Cardiovasc Surg       Date:  2016-10-24       Impact factor: 5.209

4.  The extracellular isoform of superoxide dismutase has a significant impact on cardiovascular ischaemia and reperfusion injury during cardiopulmonary bypass.

Authors:  Antonio Pinto; Moritz Benjamin Immohr; Annika Jahn; Alexander Jenke; Udo Boeken; Artur Lichtenberg; Payam Akhyari
Journal:  Eur J Cardiothorac Surg       Date:  2016-12       Impact factor: 4.191

5.  Activated protein C attenuates cardiopulmonary bypass-induced acute lung injury through the regulation of neutrophil activation.

Authors:  Sachiko Yamazaki; Syunji Inamori; Takeshi Nakatani; Michiharu Suga
Journal:  J Thorac Cardiovasc Surg       Date:  2010-07-04       Impact factor: 5.209

6.  Curcumin attenuates cardiopulmonary bypass-induced lung oxidative damage in rats.

Authors:  Kun Liu; Hong-Lin Chen; Hua Huang; Hua Jing; Guo-Hua Dong; Hai-Wei Wu; Qing-Sheng You
Journal:  J Cardiovasc Pharmacol Ther       Date:  2012-04-06       Impact factor: 2.457

7.  Deep anesthesia worsens outcome of rats with inflammatory responses.

Authors:  Kei Inoue; Takeshi Suzuki; Toru Igarashi; Shizuka Minamishima; Hiroyuki Seki; Shizuko Kosugi; Nobuyuki Katori; Hiroshi Morisaki
Journal:  Inflamm Res       Date:  2016-03-21       Impact factor: 4.575

8.  Dynamic changes in HMGB1 levels correlate with inflammatory responses during cardiopulmonary bypass.

Authors:  Zhiwei Zhang; Yuan Wu; Yuan Zhao; Xianzhong Xiao; Junwen Liu; Xinmin Zhou
Journal:  Exp Ther Med       Date:  2013-03-22       Impact factor: 2.447

9.  A novel survival model of cardioplegic arrest and cardiopulmonary bypass in rats: a methodology paper.

Authors:  Fellery de Lange; Kenji Yoshitani; Mihai V Podgoreanu; Hilary P Grocott; G Burkhard Mackensen
Journal:  J Cardiothorac Surg       Date:  2008-08-19       Impact factor: 1.637

10.  Impact of serum biomarkers and clinical factors on intensive care unit mortality and 6-month outcome in relatively healthy patients with severe pneumonia and acute respiratory distress syndrome.

Authors:  Chia-Cheng Tseng; Wen-Feng Fang; Sum-Yee Leung; Hung-Chen Chen; Ya-Chun Chang; Chin-Chou Wang; Huang-Chih Chang; Meng-Chih Lin
Journal:  Dis Markers       Date:  2014-03-03       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.